Latest Headlines

  1. Sartorius Stedim Biotech Launches New Services For Mammalian Cell Bank Manufacturing
    8/8/2019

    Sartorius Stedim Biotech (SSB), a leading partner of the biopharmaceutical industry, recently announced the launch of new services for mammalian cell bank manufacture under GMP conditions.

  2. Avalon GloboCare, GE Healthcare To Accelerate Bioproduction Of Cellular Medicines
    7/24/2019

    Avalon GloboCare Corp., a leading clinical-stage global developer of cell-based technologies and therapeutics, has announced that they have established a strategic partnership with GE Healthcare.

  3. IPS Provides Engineering Solutions To BWXT For The Development And Commercialization Of Diagnostic Medical Isotopes
    7/17/2019

    IPS-Integrated Project Services, ULC, a leading provider of Engineering, Procurement, Construction Administration and Validation (EPCAV) services, was selected by BWXT ITG Canada, Inc. to provide Basis of Design and Detailed Design for BWX Technologies, Inc.'s (BWXT) isotope project, specifically the expansion of their medical isotope and radiopharmaceutical facility in Ottawa, Ontario, Canada.

  4. Kite, A Gilead Company, Announces Plans For New 67,000-Square-Foot Cell Therapy Manufacturing Facility In CA; Dedicated To Viral Vectors
    7/16/2019

    Kite, a Gilead Company, recently announced plans for a new 67,000-square-foot facility in Oceanside, California, dedicated to the development and manufacturing of viral vectors, a critical starting material in the production of cell therapies.

  5. IPS To Design New Nexus Pharmaceuticals Manufacturing Facility In Wisconsin
    7/12/2019

    Nexus Pharmaceuticals Inc., a woman-owned, privately held, US-based healthcare company, announced recently an agreement with the village of Pleasant Prairie, Wisconsin to build an industry-leading sterile injectable manufacturing facility.

  6. Lupin Project Wins ENR Global Best Project Award Of Merit: Manufacturing
    7/11/2019

    ENR's Global Best Projects identifies and honors the project teams behind outstanding design and construction efforts of the past year. They received a record number of entries produces a diverse set of projects located in 20 countries that focused on safety performance, innovations, challenges, and design and construction quality - with a special emphasis on the diversity of global project teams and their collaboration.

  7. FUJIFILM Irvine Scientific Announces Plans for New Cell Culture Media Manufacturing Facility in Europe
    7/8/2019

    FUJIFILM Irvine Scientific, Inc., a global leader in the innovation, development, and manufacture of cell culture media, announced plans to open a third manufacturing facility located in Tilburg, Netherlands. The company currently has sites in the United States and Japan. Fujifilm’s investment in this project demonstrates its commitment to accelerate development in bioproduction, and cell and gene therapy markets.

  8. Beckman Coulter Life Sciences Acquires Cytobank
    6/4/2019

    Beckman Coulter Life Sciences today announced its acquisition of Cytobank, a privately held, single cell data analysis, software as a service (SaaS) company based in Santa Clara, California.

  9. Aldevron To Build 14-Acre Gene Therapy Manufacturing Campus
    6/3/2019

    Aldevron, a leader in the production of plasmid DNA, proteins, mRNA and antibodies; announced today expansion plans for a 14-acre campus at its headquarters in Fargo, N.D. Phase one construction will begin in August. Upon completion of the campus, the annual capacity will exceed $1 Billion of plasmid DNA, RNA, gene editing enzymes, and other biologics.

  10. Iovance Biotherapeutics Announces New Manufacturing Facility Plans For Cell Therapy Production
    5/29/2019

    Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that it has entered into a lease agreement to build an approximately 136,000 square foot commercial-scale production facility in Philadelphia for commercial and clinical production of autologous TIL products, including its candidate lifileucel.